News
AVR
7.74
+0.65%
0.05
Anteris Extends Key Supply and Quality Agreement Term
TipRanks · 5d ago
Weekly Report: what happened at AVR last week (0914-0918)?
Weekly Report · 09/21 09:03
Anteris Technologies Enhances Executive Equity-Based Compensation Plans
TipRanks · 09/17 21:30
Weekly Report: what happened at AVR last week (0907-0911)?
Weekly Report · 09/14 09:03
Anteris Technologies Global Appoints New Chief Financial Officer
TipRanks · 09/08 11:33
Weekly Report: what happened at AVR last week (0831-0904)?
Weekly Report · 09/07 09:03
Major Investor Quietly Trims Stake in Anteris Technologies Global Corp.
TipRanks · 09/02 02:08
Anteris to Present at September Healthcare Investor Conferences
Barchart · 08/31 13:45
Weekly Report: what happened at AVR last week (0824-0828)?
Weekly Report · 08/31 09:03
Weekly Report: what happened at AVR last week (0817-0821)?
Weekly Report · 08/24 09:04
Weekly Report: what happened at AVR last week (0810-0814)?
Weekly Report · 08/17 09:04
Cantor Fitzgerald Remains a Buy on Anteris Technologies Global Corp. (AVR)
TipRanks · 08/14 12:18
Anteris Techs Glbl Price Target Maintained With a $15.00/Share by Cantor Fitzgerald
Dow Jones · 08/14 10:47
Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target
Benzinga · 08/14 10:37
Analysts Offer Insights on NA Companies: BETA Technologies, Inc. Class A (BETA) and Anteris Technologies Global Corp. (AVR)
TipRanks · 08/13 11:00
Anteris Technologies Global Corp. reports Q2 results
Seeking Alpha · 08/12 12:48
Anteris Advances DurAVR Toward Commercialization; PARADIGM Trial Expands U.S. Recruitment
NASDAQ · 08/12 12:02
Reported Earlier, Anteris Technologies Glb Q2 EPS $(0.30) Misses $(0.21) Estimate, Sales $1.009M Miss $1.500M Estimate
Benzinga · 08/12 07:29
*Anteris Technologies 2Q Sales $1.01M
Dow Jones · 08/11 23:07
*Anteris Technologies 2Q Loss/Shr 30c
Dow Jones · 08/11 23:06
More
Webull provides a variety of real-time AVR stock news. You can receive the latest news about ANTERIS TECHNOLOGIES GLOBAL through multiple platforms. This information may help you make smarter investment decisions.
About AVR
Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company's ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.